insights_auto
Outlook: 44.9% bullish·6.1% bearish
Go to analysischevron_right
MRK:NYSE
Merck & Co Inc
$142.38
arrow_downward
-0.29%(-0.41) 1D
$142.37
arrow_downward
-0.01% (-0.0081)bedtimeAfter hours
Closed: Oct 8, 4:03:46 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MRK...
Open
$141.90
High
$142.77
Low
$138.89
Mkt. cap
351.28B
Avg. vol.
9.41M
Volume
0.00
Dividend
2.39%
Quarterly dividend
$0.85
Ex-dividend date
Sep 15, 2026
P/E ratio
113.72
52-wk high
$156.92
52-wk low
$82.01
EPS
$1.25
Beta
0.21
Shares outstanding
2.47B
No. of employees
74K
Open
$141.90
High
$142.77
Low
$138.89
Mkt. cap
351.28B
Avg. vol.
9.41M
Volume
0.00
Dividend
2.39%
Quarterly dividend
$0.85
Ex-dividend date
Sep 15, 2026
P/E ratio
113.72
52-wk high
$156.92
52-wk low
$82.01
EPS
$1.25
Beta
0.21
Shares outstanding
2.47B
No. of employees
74K
News stories
From web sources and news partners
MarketBeat
·
8 minutes ago
Farther Finance Advisors LLC Acquires 11,956 Shares of Merck & Co., Inc. $MRK
Kalkine Media
·
4 hours ago
Is Merck (NYSE:MRK) Firming as Capital Rotates Toward Healthcare?
Zacks
·
15 hours ago
HALO Wins Court Order Blocking Merck's Keytruda SC in Europe
Zacks
·
16 hours ago
Pfizer's Oncology Outlook: Key Drivers to Watch Ahead of Q3 Results
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74K
FoundedJan 1, 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com